FY2026 Earnings Forecast for ISRG Issued By Erste Group Bank

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Analysts at Erste Group Bank dropped their FY2026 earnings per share (EPS) estimates for Intuitive Surgical in a research note issued to investors on Thursday, April 2nd. Erste Group Bank analyst H. Engel now expects that the medical equipment provider will post earnings of $8.21 per share for the year, down from their previous forecast of $8.22. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share.

Several other equities research analysts also recently commented on ISRG. Truist Financial boosted their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Evercore decreased their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a report on Monday. Finally, HSBC boosted their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a report on Monday, January 26th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $607.00.

Intuitive Surgical Stock Up 2.1%

NASDAQ ISRG opened at $462.28 on Thursday. The company has a market cap of $164.17 billion, a price-to-earnings ratio of 58.59, a P/E/G ratio of 3.49 and a beta of 1.68. Intuitive Surgical has a 52 week low of $427.84 and a 52 week high of $603.88. The business has a 50 day moving average price of $483.27 and a 200-day moving average price of $514.06.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.21 earnings per share.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. SteelPeak Wealth LLC lifted its position in shares of Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after acquiring an additional 9,364 shares in the last quarter. Atlantic Union Bankshares Corp raised its stake in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after purchasing an additional 3,676 shares during the period. World Investment Advisors raised its stake in shares of Intuitive Surgical by 238.3% during the 3rd quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock valued at $2,415,000 after purchasing an additional 3,803 shares during the period. E. Ohman J or Asset Management AB raised its stake in shares of Intuitive Surgical by 4.1% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 28,306 shares of the medical equipment provider’s stock valued at $12,659,000 after purchasing an additional 1,123 shares during the period. Finally, Valley Wealth Managers Inc. raised its stake in shares of Intuitive Surgical by 52.7% during the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock valued at $1,826,000 after purchasing an additional 1,409 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 2,362 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 32,943 shares of company stock valued at $17,279,568 over the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive’s push to embed AI into its da Vinci systems reinforces the company’s long‑term growth and margin story, supporting investor confidence in recurring procedure growth and software monetization. AI Push Article
• Positive Sentiment: Goldman Sachs kept a Buy rating on ISRG, signaling continued institutional support despite lowering its price target to $609 — the maintained Buy reduces downside risk for some investors. Goldman Sachs PT Article
• Positive Sentiment: Third‑party coverage highlights Intuitive’s strong balance sheet (no debt) and near‑monopoly position in robotic surgery — a supportive fundamental narrative for long‑term investors. Fool No‑Debt Article
• Positive Sentiment: Analysts and commentators point to an underappreciated large opportunity in anti‑obesity procedures that could widen Intuitive’s TAM and future procedure volumes. Anti‑Obesity Opportunity Article
• Neutral Sentiment: Market summaries note ISRG rose today but underperformed the market, suggesting selective buying rather than broad momentum. Zacks Market Summary
• Neutral Sentiment: Erste Group trimmed FY2027 EPS estimates very slightly (from $9.54 to $9.52) — the change is immaterial to near‑term outlook but reflects close monitoring of margins and procedure growth.
• Negative Sentiment: Evercore published a pessimistic forecast for ISRG, introducing downside bias from a well‑known sell‑side voice that can influence short‑term flows and sentiment. Evercore Forecast Article
• Negative Sentiment: Goldman’s sizable cut to its price target (from $714 to $609) signals valuation pressure — even with a Buy rating, lower targets can prompt profit‑taking or cap repositioning by funds. Goldman Sachs PT Article

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.